Immunotherapy for Cancer: Types, Benefits, Side Effects & What to Expect

CAR-T Cell Therapy
clinical trials
lung cancer
melanoma
lymphoma

Immunotherapy is a type of cancer treatment that helps the immune system recognize and fight cancer more effectively. It includes several approaches, such as checkpoint inhibitors and CAR-T or other T-cell transfer therapies, and it is used in different ways depending on the cancer type, stage, and treatment goal

What Immunotherapy Is

Immunotherapy Comparison
Checkpoint Inhibitors vs CAR-T vs Other Immunotherapy
What it is
Checkpoint
Drugs that remove “brakes” on immune cells.
CAR-T
Engineered T cells reinfused to attack cancer.
Other
Antibodies, vaccines, cytokines, immune modulators.
How it works
Reactivates existing immune response.
Adds new targeting ability to T cells.
Multiple immune activation pathways.
Clinical idea
Removes suppression of immunity.
Personalized living cell therapy.
Broader immune system modulation.
Position
Widely used across many cancers.
Specialized relapsed/refractory setting.
Supportive / expanding landscape.
trial-match

Checkpoint Inhibitors vs CAR-T

These two treatments are both immunotherapy, but they work very differently.

Checkpoint Inhibitors vs CAR-T
Simple clinical comparison
Checkpoint Inhibitors
Drugs that remove “brakes” on the immune system so existing immune cells can attack cancer more effectively.
CAR-T Therapy
Personalized cell therapy where a patient’s T cells are collected, engineered in a lab, and reinfused to target cancer directly.
Use in Cancer
Widely used in many solid tumors such as lung cancer and melanoma, and other indications depending on the drug.
Use in Cancer
Mainly used in selected blood cancers such as leukemias, lymphomas, and multiple myeloma in specific settings.
Quick Comparison
Checkpoint inhibitors Immune “brake release” drugs
CAR-T Engineered living T-cell therapy
Checkpoint inhibitors Broad use in solid tumors
CAR-T Mainly blood cancers

Who May Benefit from Immunotherapy

Not every patient benefits from immunotherapy in the same way. Whether immunotherapy is considered depends on the cancer type, stage, biomarkers, previous treatments, and overall treatment plan. Checkpoint inhibitors are used in multiple cancers, while CAR-T is currently used more selectively.

Immunotherapy
Cancers commonly linked to immunotherapy in patient education

Patient-facing sources commonly discuss immunotherapy in cancers such as lung cancer, melanoma, and some lymphomas, among others. Whether it is appropriate still depends on the specific case.

Important expectation-setting

This page should say clearly that immunotherapy can be very effective for some people, but it does not work for everyone, and it can cause serious side effects that need quick medical attention. ACS notes that immune-related side effects can happen during treatment or sometimes even after stopping treatment.

Side Effects

Immunotherapy Side Effects
Checkpoint inhibitors vs CAR-T toxicity profile
Common checkpoint inhibitor side effects
These can occur during treatment and affect daily comfort, energy, skin, and digestion.
Rash
Diarrhea
Fatigue
Fever
Cough
Nausea
Itching
Appetite loss
Constipation
More serious immune-related side effects
These occur when inflammation affects organs or hormone systems and require prompt medical attention.
Lungs
Colon
Liver
Kidneys
Skin
Heart
Nervous system
Thyroid / adrenal / pituitary
CAR-T side effects
CAR-T has a distinct toxicity profile. Key risks include cytokine release syndrome (CRS) and neurologic toxicity (ICANS).
Fever
Low blood pressure
Rapid heartbeat
Trouble breathing
Confusion
Headache
Nausea
Neurologic symptoms

Side-Effect Decision

When to Act on Immunotherapy Side Effects
Simple escalation guide for patients and caregivers
1
Mild but new symptoms
Examples
Mild rash, itching, mild diarrhea, unusual fatigue, or reduced appetite.
Rash • Itching • Mild diarrhea • Fatigue • Appetite changes
Tell your cancer team promptly. Do not assume symptoms are unrelated. Many side effects are easier to manage when caught early.
2
Worsening symptoms
Examples
Worsening diarrhea, cough, breathlessness, severe rash, vomiting, weakness, confusion, or headaches.
GI worsening • Breathing issues • Neurologic changes • Severe fatigue
Contact the treatment team urgently the same day.
3
Emergency-type symptoms
Examples
Trouble breathing, chest pain, severe confusion, high fever, dizziness, low blood pressure symptoms, or severe reaction during/after treatment.
Breathing distress • Chest pain • High fever • Shock symptoms • Severe confusion
Seek urgent medical help immediately. Tell providers you are on immunotherapy or recent CAR-T therapy.

Monitoring and Safety

Patients receiving immunotherapy are commonly monitored with symptom review, blood tests, and clinical follow-up because side effects can affect organs even when symptoms seem vague at first. NHS cancer-center guidance notes that blood tests may be used to monitor for certain immunotherapy side effects, and some immune-related problems may require steroids or other immunosuppressive treatment.

Do not ignore new symptoms during immunotherapy, even if they seem small.
That message is well supported by NCI, ACS, and NHS-style materials because early recognition can matter.

Patient guidance also notes that side effects may be more likely or more severe when immunotherapy is combined with another immunotherapy drug or with chemotherapy.

Clinical Trials

Clinical trials continue to play a major role in immunotherapy, including testing new checkpoint inhibitor combinations, better ways to use CAR-T, and strategies to make treatments work for more patients or different cancer types. NCI continues to report active research in this area.

Download side-effect guide

Questions to Ask Your Oncology Team

What type of immunotherapy is being considered for me?
Is this a checkpoint inhibitor, CAR-T, or another form of immunotherapy?
Why do you think this treatment may help in my case?
What side effects are most likely, and which are urgent?
How will I be monitored during treatment?
Could side effects happen after treatment ends?
What should I do if I get diarrhea, rash, fever, cough, or unusual fatigue?
Would a clinical trial be appropriate for me?
How does immunotherapy compare with chemotherapy, radiation, or other options in my case?

FAQ

What is immunotherapy for cancer?

Immunotherapy is a type of cancer treatment that helps the immune system fight cancer.

Checkpoint inhibitors are drugs that block signals cancer uses to turn immune cells off, helping the immune system attack cancer more effectively.

CAR-T therapy is a type of T-cell transfer therapy in which a patient’s T cells are collected, changed in a lab to better recognize cancer, and then given back to the patient.

Common side effects can include fatigue, rash, itching, diarrhea, nausea, appetite changes, and other immune-related effects depending on which organs are affected.

Yes. Immunotherapy can sometimes cause serious inflammation in organs such as the lungs, colon, liver, hormone glands, heart, or nervous system, and CAR-T can cause cytokine release syndrome and neurologic problems.

Cancer treatments:

CAR-T Cell Therapy
CAR-T for Solid Tumors
TIL Therapy
Immunotherapy
Cancer Surgery
Chemotherapy
Radiation Therapy
Hormone Therapy

Medical Disclaimer & Source References
© BEIJING BIOTECH.
Clinical Sources: NCCN, ASCO, ACS, ESMO, CSCO, CACA, ChiCTR.
Treatment Note: Immunotherapy is not appropriate for every cancer or every patient. Benefits and side effects vary by treatment type and setting.

Scroll to Top